ãŠãã€ãããã»ã»ã©ãã¥ãŒãã£ã¯ã¹ã5å2500äžãã«ã§ã©ãªããã°ã®ãã€ã€ãªãã£ãè²·ãæ»ã
ãŠãã€ãããã»ã»ã©ãã¥ãŒãã£ã¯ã¹ã¯ããã¡ã€ã¶ãŒåäŒç€Ÿã®ã¢ãªãŒãã»ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºãšã®éã§ãã©ãªããã°ã«é¢ããç¬å ã©ã€ã»ã³ã¹å¥çŽã®ä¿®æ£ã«åæãããå瀟ã¯5å2,500äžãã«ã®åæãéãæ¯æããçµå£ããã³åžå ¥è£œå€ãå«ãå šè£œå€ã«é¢ããå°æ¥ã®ãã€ã€ãªãã£çŸ©åãå®å šã«è§£æ¶ãããåœåå¥çŽã§ã¯çŽå£²äžé«ã«å¯Ÿã10%å°ååã®ãã€ã€ãªãã£æ¯æããå®ããããŠããããä»åã®è²·åã«ããé·æçãªã³ã¹ãè² æ ã軜æžãããå°æ¥ã®å©ççæ¹åã«ã€ãªããéèŠãªæŠç¥çååŒãšãªãã
ãŠãã€ãããã»ã»ã©ãã¥ãŒãã£ã¯ã¹ïŒNasdaq: UTHRïŒã¯ããã¡ã€ã¶ãŒïŒPfizer Inc.ïŒã®åäŒç€Ÿã§ããã¢ãªãŒãã»ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºïŒArena Pharmaceuticals, Inc.ïŒãšã®éã§ãã©ãªããã°ã«é¢ããç¬å ã©ã€ã»ã³ã¹å¥çŽã®ä¿®æ£å¥çŽãç· çµãããšçºè¡šããã
æ¬ä¿®æ£å¥çŽã«åºã¥ãããŠãã€ãããã»ã»ã©ãã¥ãŒãã£ã¯ã¹ã¯5å2,500äžãã«ã®åæãéãæ¯æãããšã§ãã©ãªããã°ã«é¢é£ãããã¹ãŠã®ãã€ã€ãªãã£çŸ©åãè§£æ¶ããããã®ãã€ã€ãªãã£ã®è§£æ¶ã¯ãçµå£è£œå€ããã³åžå ¥è£œå€ãå«ãã©ãªããã°ã®å šè£œå€ã察象ãšããŠããã
åœåã®å¥çŽã§ã¯ããŠãã€ãããã»ã»ã©ãã¥ãŒãã£ã¯ã¹ã«ããå šã©ãªããã°è£œå€ã®çŽå£²äžé«ã«å¯ŸããŠ10%å°ååã®ãã€ã€ãªãã£ãæ¯æãããšãå®ããããŠããã
ãã®èšäºã®äžéšã¯AIã«ãã£ãŠçæã»ç¿»èš³ããã人éã«ããã¬ãã¥ãŒãçµãŠããŸããããã¯äžè¬çãªæ å ±æäŸã®ç®çã§ã®ã¿äœ¿çšãããŠãããæè³ã¢ããã€ã¹ãæ§æãããã®ã§ã¯ãããŸããã
ããããèšäº








ã³ã¡ã³ã (0)
$ãã¿ã³ãã¯ãªãã¯ããã·ã³ãã«ãå ¥åããŠãæ ªåŒãETFããŸãã¯ãã®ä»ã®ãã£ãã«ãŒã·ã³ãã«ããªã³ã¯ããŸãã